MarketNewsUpdates News Commentary NEW YORK, Sept. 11, 2025 /PRNewswire/ -- The global Diagnostic Biomarker market is experiencing unprecedented growth and is projected to continue to see substantial growth in years to come. A recent report from the (NIH) National Library of Medicine discussed the AI-Assisted Biomarker, said that: "Recently, advancements in healthcare digitization and personalized treatments have led to groundbreaking developments. Utilization of AI and ML has the potential to enhance comprehension of disease onset and progression, potentially uncovering new disease subtypes, unveiling novel drug targets, advancing the field of precision medicine, propelling efforts towards d

Annualized run-rate revenue(1) (ARR) guidance increased to $900 million to $1.1 billion for the end of 2025 Revenue for Q2 of $105.1 million, up 625% year-on-year and 106% quarter-on-quarter Core business achieves positive Adjusted EBITDA ahead of plan In the process of securing more than 1 GW of power by the end of 2026 Nebius Group N.V. (NASDAQ:NBIS), a leading AI infrastructure company, today announced its unaudited financial results for the second quarter ended June 30, 2025. "Nebius is continuing to deliver exceptional results," said founder and CEO Arkady Volozh. "In Q2 we more than doubled revenue from the previous quarter, and our core business achieved positive Adjus

Seaport Research Partners initiated coverage of Nebius Group N.V. with a rating of Neutral

Goldman initiated coverage of Nebius Group N.V. with a rating of Buy and set a new price target of $68.00

Arete initiated coverage of Nebius Group N.V. with a rating of Buy and set a new price target of $84.00

Northland Capital initiated coverage of Nebius Group N.V. with a rating of Outperform and set a new price target of $34.00

DA Davidson initiated coverage of Nebius Group N.V. with a rating of Buy and set a new price target of $50.00

BWS Financial reiterated coverage of Nebius Group N.V. with a rating of Buy and set a new price target of $60.00 from $51.00 previously

BWS Financial initiated coverage of Nebius Group N.V. with a rating of Buy and set a new price target of $51.00

FWP - Nebius Group N.V. (0001513845) (Subject)

FWP - Nebius Group N.V. (0001513845) (Subject)

FWP - Nebius Group N.V. (0001513845) (Subject)

424B5 - Nebius Group N.V. (0001513845) (Filer)

FWP - Nebius Group N.V. (0001513845) (Subject)

FWP - Nebius Group N.V. (0001513845) (Subject)

FWP - Nebius Group N.V. (0001513845) (Subject)

6-K - Nebius Group N.V. (0001513845) (Filer)

6-K - Nebius Group N.V. (0001513845) (Filer)

6-K - Nebius Group N.V. (0001513845) (Filer)

Nebius (NASDAQ:NBIS), a leading AI infrastructure company, today announced the appointment of Marc Boroditsky as Chief Revenue Officer as the company continues to build out its global sales team. A seasoned senior tech executive, Marc has a strong global go-to-market track record of driving high growth – in five years at Twilio he grew paying customers six times, and revenue more than 10 times to $4 billion. Previously he founded several successful companies, and served as a senior leader at Oracle and most recently Cloudflare. Arkady Volozh, founder and CEO of Nebius, welcomed Marc to the company: "We are building a global company and planning to grow many times in the coming years.

MarketNewsUpdates News Commentary NEW YORK, Sept. 11, 2025 /PRNewswire/ -- The global Diagnostic Biomarker market is experiencing unprecedented growth and is projected to continue to see substantial growth in years to come. A recent report from the (NIH) National Library of Medicine discussed the AI-Assisted Biomarker, said that: "Recently, advancements in healthcare digitization and personalized treatments have led to groundbreaking developments. Utilization of AI and ML has the potential to enhance comprehension of disease onset and progression, potentially uncovering new disease subtypes, unveiling novel drug targets, advancing the field of precision medicine, propelling efforts towards d

Nebius Group N.V. (("Nebius Group" or the "Company", NASDAQ:NBIS), a leading AI infrastructure company, today announced the pricing of its offering of $2.75 billion aggregate original principal amount of convertible senior notes, in two series: $1,375,000,000 aggregate original principal amount of 1.00% convertible notes due 2030 (the "2030 Notes") and $1,375,000,000 aggregate original principal amount of 2.75% convertible notes due 2032 (the "2032 Notes", and together with the 2030 Notes, the "Notes"), in a private offering to qualified institutional buyers pursuant to Rule 144A under the Securities Act of 1933, as amended (the "Securities Act"). The offering was upsized from the previousl

Nebius Group N.V. (("Nebius Group" or the "Company", NASDAQ:NBIS), a leading AI infrastructure company, today announced the pricing of its previously announced underwritten public offering of $1 billion of the Company's Class A ordinary shares at a public offering price of $92.50 per Class A ordinary share. In addition, the Company has granted the underwriters a 30-day option to purchase up to an additional $150 million of Class A ordinary shares at the public offering price, less underwriting discounts and commissions. The offering is expected to close on September 15, 2025, subject to customary closing conditions. Goldman Sachs & Co. LLC is acting as lead book-running manager for the pr

Nebius Group N.V. (("Nebius Group" or the "Company", NASDAQ:NBIS), a leading AI infrastructure company, today announced its intention to offer, subject to market and other conditions, $2.0 billion aggregate original principal amount of convertible senior notes, in two series: $1.0 billion aggregate original principal amount of convertible notes due 2030 (the "2030 Notes") and $1.0 billion aggregate original principal amount of convertible notes due 2032 (the "2032 Notes", and together with the 2030 Notes, the "Notes"), in a private offering to qualified institutional buyers pursuant to Rule 144A under the Securities Act of 1933, as amended (the "Securities Act"). Nebius Group also expects t

Nebius Group N.V. (NASDAQ:NBIS) ("Nebius" or the "Company"), a leading AI infrastructure company, today announced the launch of an offering of convertible notes and a concurrent offering of Class A shares to support the accelerated future growth of its core business. Our core AI cloud business is growing rapidly, and we continue to be laser focused on developing this business. We view long-term contracts such as the one we announced this week with Microsoft as important incremental sources of growth. We intend to use the net proceeds from the offerings we have announced today, if consummated, to finance the continuing growth of our business, including the acquisition of additional compu

Nebius Group N.V. (("Nebius Group" or the "Company", NASDAQ:NBIS), a leading AI infrastructure company, today announced that it has commenced an underwritten public offering of $1 billion of the Company's Class A ordinary shares. In addition, the Company intends to grant the underwriters a 30-day option to purchase up to an additional $150 million of Class A ordinary shares at the public offering price, less underwriting discounts and commissions. The offering is subject to market and other conditions, and there can be no assurance as to whether or when the offering may be completed, or as to the actual size or terms of the offering. All Class A ordinary shares to be sold in the offering wi

Latest suite of 2X long single-stock funds are all first-to-market strategies NEW YORK, Sept. 9, 2025 /PRNewswire/ -- Tradr ETFs, a provider of ETFs designed for sophisticated investors and professional traders, today announced the launch of six new single stock leveraged ETFs. The funds aim to deliver twice (200%) the daily performance of a specific underlying stock. All six funds are first-to-market strategies and are listed on Cboe: Tradr 2X Long APLD Daily ETF (APLX) – tracks Applied Digital Corp. (NASDAQ:APLD)Tradr 2X Long NBIS Daily ETF (NEBX) – tracks Nebius Group NV (NASDAQ:NBIS)Tradr 2X Long JOBY Daily ETF (JOBX) – tracks Joby Aviation Inc. (NYSE:JOBY)Tradr 2X Long NVTS Daily ETF (N

Deal enables significantly more aggressive growth of Nebius's AI cloud business in 2026 Nebius Group N.V. (NASDAQ:NBIS) ("Nebius" or the "Company"), a leading AI infrastructure company, today announced an agreement to deliver AI infrastructure to Microsoft. Under this multi-year agreement, Nebius will deliver dedicated capacity to Microsoft from its new data center in Vineland, New Jersey starting later this year. Arkady Volozh, founder and CEO of Nebius, said: "Nebius's core AI cloud business, serving customers from AI startups to enterprises, is performing exceptionally well. We have also said that, in addition to our core business, we expect to secure significant long-term comm

In the news release, Tradr Set to Launch Five First-to-Market Leveraged ETFs on APLD, NBIS, JOBY, NVTS, PONY & VOYG, issued 08-Sep-2025 by Tradr ETFs over PR Newswire, we are advised by the company that "five" should be "six" throughout the release. The complete, corrected release follows: Tradr Set to Launch Six First-to-Market Leveraged ETFs on APLD, NBIS, JOBY, NVTS, PONY & VOYG New 2X long single-stock funds focused on exciting growth verticals including AI-infrastructure and eVOTLs NEW YORK, Sept. 8, 2025 /PRNewswire/ -- Tradr ETFs, a provider of ETFs designed for sophisticated investors and professional traders, announced that tomorrow, September 9, it expects to launch six new sing

New 2X long single-stock funds focused on exciting growth verticals including AI-infrastructure and eVOTLs NEW YORK, Sept. 8, 2025 /PRNewswire/ -- Tradr ETFs, a provider of ETFs designed for sophisticated investors and professional traders, announced that tomorrow, September 9, it expects to launch five new single stock leveraged ETFs. All five funds are first-to-market strategies and will be listed on Cboe. The funds aim to deliver twice (200%) the daily performance of a specific underlying stock. Tradr launches: Tradr 2X Long APLD Daily ETF (Cboe: APLX) – tracks Applied Digital Corp. (NASDAQ:APLD)Tradr 2X Long NBIS Daily ETF (Cboe: NEBX) – tracks Nebius Group NV (NASDAQ:NBIS)Tradr 2X Long

SC 13G/A - Nebius Group N.V. (0001513845) (Subject)